FDA product code · Cardiovascular
Agent, Occluding, Vascular, Permanent
1 FDA decision since 2015. No recall names this code.
The device is a polymerizing agent intended for permanent occlusion of peripheral blood vessels.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of PJQ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · PJQ
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · PJQ
Too few PJQ 510(k)s in any year since 2007 to give a median.
Recalls per year · PJQ
No recall names PJQ since 2007.
Adverse event reports per year · PJQ
100in 2025
MAUDE reports naming product code PJQ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 2 | — | 0 | 6 |
| 2016 | 4 | — | 0 | 41 |
| 2017 | 2 | — | 0 | 69 |
| 2018 | 7 | — | 0 | 110 |
| 2019 | 3 | — | 0 | 162 |
| 2020 | 3 | — | 0 | 152 |
| 2021 | 7 | — | 0 | 161 |
| 2022 | 6 | — | 0 | 180 |
| 2023 | 5 | — | 0 | 154 |
| 2024 | 3 | — | 0 | 112 |
| 2025 | 3 | — | 0 | 100 |
| 2026 | 3 | — | 0 | — |
Planning a device in PJQ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report